Joe Giordano, surgeon who helped save President Reagan's life after assassination attempt, has died
He died on June 24 at a hospital in Washington, D.C. from an infection related to a lengthy illness, his family said.
Giordano was in charge of The George Washington University Hospital's trauma teams that treated Reagan after the president had been shot and badly wounded on March 30, 1981. Over the course of several dramatic hours, doctors stabilized Reagan, retrieved a bullet an inch from his heart and stanched massive internal bleeding.
'Dr. Giordano and the doctors at GW, without them, Ronald Reagan would have died,' said Jerry Parr, the president's lead Secret Service agent at the time, in a 2010 interview for the book " Rawhide Down.'
Revamps GW
emergency room
Giordano, the grandson of Italian immigrants, was born and raised in New Jersey. He graduated from Georgetown University in 1961 and six years later obtained a medical degree from Jefferson Medical College in Philadelphia.
After a stint in the U.S. Army, he joined GW as a vascular surgeon. A few weeks before he started in 1976, GW's chief of surgery told Giordano that he would have another job — fixing and managing the emergency room.
'The handling of trauma patients down there is a real mess,' his boss said.
Giordano quickly discovered that assessment was correct. Inexperienced doctors were leading inefficient medical teams. Care was haphazard. Giordano watched as at least one patient died because treatment was rendered too slowly.
Seeking out experts, he spent a month working at what would become the R Adams Cowley Shock Trauma Center at the University of Maryland. The teams at Shock Trauma operated with speed and precision. They were methodical. He brought the approach to GW. Soon, the hospital's trauma center was regarded as among the best in the country.
'We had everything going like clockwork,' said Dr. David Gens, who helped treat Reagan and went on to a long career in trauma surgery. 'Joe had us properly trained. We had the right protocols. Everyone had a job. Organization and time are essential. So that when something happened, when the president came in, we were well organized. Thanks in part to Joe's foresight, we saved the president's life.'
'STAT to the ER'
It was a typical March Monday for Giordano when a would-be assassin, John Hinckley, Jr., opened fire on Reagan as the president left a speech at the Washington Hilton Hotel. Parr, the Secret Service agent, shoved Reagan into a limousine, and it hurtled from the scene. On the ride back to the White House, Parr realized Reagan had been hurt, perhaps from being flung into the armored Lincoln. Not knowing the extent of the injuries — doctors would soon discover he had been shot — Parr directed the limousine to the hospital.
At GW Giordano was treating a patient when the intercom began blaring: 'Dr. Giordano, STAT to the ER. Dr. Giordano, STAT to the ER.' Though he had turned over responsibility for running the emergency room to another doctor, Giordano was still in charge of the trauma teams. He knew something must be terribly wrong for him to be summoned that way.
In the ER, he found a man he recognized as the president on gurney. Nurses had already cut off Reagan's clothes and inserted IV lines. Strangely, the first thing that Giordano noticed about the president was his dark hair. It seemed so natural. 'I wondered,' Giordano recalled in a 2010 interview, 'if he dyed it.'
'How are you doing, Mr. President?' he asked.
'I'm having trouble breathing,' Reagan replied.
Bleeding won't stop
Gens, a chief surgical resident, provided Giordano a quick summary of the situation: The president had been shot in the left side, his chest was filling with blood and they were about to insert a chest tube to drain the chest cavity.
Giordano did not hesitate. 'You better let me do this one.' He typically would have let a resident handle such a procedure, but he felt it would be irresponsible to put such pressure on young doctors. He made an incision eight inches below Reagan's left armpit and inserted the tube.
It relieved pressure on Reagan's lung and allowed him to breathe more easily. But the bleeding did not stop. Doctors decided they had to operate.
Giordano and Gens performed a peritoneal lavage — known as a 'belly tap' — and ensured that Reagan's abdomen was clear of blood. They then turned over the patient to a chest surgeon, Dr. Benjamin Aaron, who halted the bleeding and retrieved the bullet.
Reagan spent 11 days at GW and fully recovered from his wounds. Three others were injured in the shooting: White House Press Secretary Jim Brady; Secret Service agent Timothy McCarthy; and Thomas Delahanty, a police officer.
Hinckley was found not guilty by reason of insanity. He was confined at a psychiatric hospital until a federal judge in 2022 ordered his unconditional release.
'Today, Mr. President, we are all Republicans'
Giordano would go on to become GW's chairman of surgery, a post he held for 18 years before retiring in 2010.
That same year, he joined the board at Partner for Surgery, a nonprofit group that arranges surgery for people living in rural Guatemala. Tapping his contacts in the medical community, Giordano recruited doctors and nurses to travel to the Central American country to provide the badly needed medical services, said Frank Peterson, the group's founder. Giordano also led several medical teams on such missions.
'The one word I would use to describe him is humanitarian,' Peterson said. 'He had the skills and capabilities that made a world of difference to people who were in need.'
Though Giordano played a decisive role in saving Reagan's life, the physician may best be remembered for a line he delivered in the operating room.
Just before he was administered anesthesia, Reagan dramatically got up on an elbow, took off his oxygen mask and said, 'I hope you are all Republicans.'
Giordano, a staunch liberal, didn't miss a beat: 'Today, Mr. President, we are all Republicans.'
Years later, the surgeon jokingly reflected that 'it was okay to be a Republican for a day, especially that day.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
6 minutes ago
- Bloomberg
Longevity Episode 1: Obesity
In the premiere episode of 'Longevity," David Rubenstein explores the ongoing obesity crisis in America, examining its longstanding impact and the latest medical advancements aimed at addressing it, most notably the development of GLP-1s. He also delves into the question of whether weight-loss drugs offer a lasting solution. (Source: Bloomberg)
Yahoo
33 minutes ago
- Yahoo
Boston Scientific lifts annual profit view on steady heart devices demand
(Reuters) -Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S. medical device maker beat second-quarter profit estimates. Shares of the Massachusetts-based company rose 2.3% in premarket trading following the results. A rise in surgical procedures has benefited medical device manufacturers such as Boston Scientific, as it boosted sales and helped offset broader concerns about healthcare spending pressures. Analysts said hospital utilization trends were robust during the second quarter, with hospital checks pointing to high single-digit volume growth - well above the historical average. Boston Scientific's main growth drivers, Farapulse and Watchman, which use short high-voltage pulses to treat certain abnormal heart rhythm conditions, saw strong demand during the quarter. Farapulse, approved in the U.S. to treat certain patients with intermittent atrial fibrillation, competes with Johnson & Johnson's Varipulse and Medtronic's PulseSelect in the market for pulsed field ablation (PFA) systems. "Cardiovascular end-markets remain robust," Truist analyst Richard Newitter said ahead of the earnings, adding that Boston, followed by Medtronic, are in the best position at the moment to benefit from the growing and accelerating PFA market. Rival Johnson & Johnson last week posted strong medtech sales, aided by its heart devices, Varipulse and Trupulse. Boston Scientific expects 2025 adjusted profit of $2.95 to $2.99 per share, up from the prior view of $2.87 to $2.94 earlier. It posted adjusted profit of 75 cents per share for the second quarter, topping analysts' average estimate of 72 cents, according to data compiled by LSEG. The company's cardiovascular unit reported quarterly sales of $3.34 billion, surpassing estimates of $3.20 billion. Revenue came in at $5.06 billion for the quarter, topping estimates of $4.9 billion.
Yahoo
33 minutes ago
- Yahoo
One A Day® Launches First of its Kind Multivitamin Gummy with Iron to Help Fill Nutrient Gaps in Kids
One A Day® Kids Multi with Iron provides 2/3 of the recommended daily value of Iron and is one of three offerings in the new Kids' line WHIPPANY, N.J., July 23, 2025--(BUSINESS WIRE)--One A Day®, the multivitamin and supplement brand rooted in 80+ years of nutritional science, announced the launch of One A Day® Kids Multi with Iron, a gummy multivitamin with 12mg of iron per serving1—no kids multivitamin gummy among leading brands has more iron—to help fill nutrient gaps kids may have. Iron is an essential mineral for healthy growth and development. As picky eating behavior is common according to a new survey sponsored by One A Day®, children may be falling short of important nutrients like iron. The survey sponsored by One A Day® reveals that mealtime can often feel like a standoff for parents and kids, with approximately two-thirds (66%) sharing that their child refuses meals at least once a week and more than half (54%) say their child mostly eats snacks, while refusing full meals. This can make it challenging to help kids get enough of the key nutrients they may need for healthy development and highlights the need for nutritional support during this picky phase. The survey also found that over half (51%) of parents worry their child's eating habits will affect growth and development, with 46% saying that managing their child's eating habits is a top parenting concern – even ahead of screentime. To shed light on the ways that parents can help kids get enough daily nutrients, One A Day® Kids is partnering with Dr. Jessica Andrade, board certified pediatrician. "Through my experience working with children and their families, I know how important good, balanced nutrition is for supporting kids' healthy development," shares Dr. Andrade. "Iron is one of the most common nutritional deficiencies in children, and it is crucial to their development. Adding these vitamin gummies to children's daily routines is a simple and tasty way to help meet daily iron needs, especially when they may lack iron in their diets." One A Day® Kids Multi with Iron is one of three offerings in the new One A Day Kids' line. These easy-to-chew gummy multivitamins are specially formulated with key nutrients for kids to support overall healthy growth and development as well as eye, brain, and immune health. One A Day® Kids Multi with Iron Gummies provides key nutrients and an excellent source of iron with 12mg of iron in two gummies a day – providing ⅔ of the recommended Daily Value for this key nutrient. One A Day® Kids Multi With Probiotic Gummies contains essential nutrients, and a probiotic clinically tested in kids. It includes 1 billion CFUs of Bacillus Subtilis DE111® probiotic per serving (2 gummies) to support gut health. One A Day® Kids Multi Gummies is formulated with 9 key vitamins and minerals, offering nutritional support in delicious natural fruit flavors orange, raspberry, and cherry2. "As a brand dedicated to providing consumers with nutritional support at important life stages, we know how important it is for parents to have a trusted multivitamin that kids actually want to take because they like the taste and texture. That's why we are excited to introduce the new One A Day® Kids line including the first of its kind gummy multivitamin with iron for kids," says Lisa Perez, mom of three and General Manager Nutritionals at Bayer, the maker of One A Day®. One A Day® Kids Gummies are formulated with good stuff parents want, without stuff they don't: free of artificial sweeteners, high fructose corn syrup and egg, fish/crustacean shellfish, and dairy (milk) – making them a great option for helping little ones thrive. With this launch, One A Day® reaffirms its commitment to providing consumers with high-quality multivitamins specially designed for different life stages, genders, ages, or health goals. For more information on One A Day® Kids, visit Benefit claims for One A Day(R) Kids Multi Gummies have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. DE111(R) is a trademark of Deerland Probiotics & Enzymes, Inc. 1 One serving = two gummies 2 Natural orange, raspberry and cherry flavors with other natural flavors Research MethodologyBayer sponsored an online survey for One A Day® Vitamins from 3/19/2025 to 3/23/2025 to explore how pickiness manifests in children and understand the real-life impact it has on parents. The survey included 1,000 U.S. adults with children ages 4-10 years old, balanced by gender and region to reflect U.S. census demographics. About One A Day®One A Day is a multivitamin and supplement brand offering specially formulated products for many members of the family. From prenatal to 65+, One A Day offers products for different ages, genders and health goals. The portfolio includes tablet, softgel, capsule, and gummy products. One A Day products are available at most major drug stores and retailers nationwide. About BayerBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to Forward-Looking StatementsThis release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. View source version on Contacts Jan SchlegelmilchDirector, Integrated Communications, U.S. Consumer Bryan GibbsVice President, Media, twelvenote agencybgibbs@ Sign in to access your portfolio